Arrowstreet Capital’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-134,643
| Closed | -$10.8M | – | 2419 |
|
|
2021
Q1 | $10.8M | Buy |
+134,643
| New | +$10.5M | 0.01% | 853 |
|
|
2020
Q2 | – | Sell |
-35,310
| Closed | -$1.27M | – | 2509 |
|
|
2020
Q1 | $1.27M | Buy |
+35,310
| New | +$2.01M | ﹤0.01% | 1230 |
|
|
2018
Q4 | – | Sell |
-98,105
| Closed | -$9.03M | – | 1574 |
|
|
2018
Q3 | $9.03M | Buy |
98,105
+89,252
| +1,008% | +$8.5M | 0.02% | 425 |
|
|
2018
Q2 | $871K | Buy |
+8,853
| New | +$990K | ﹤0.01% | 829 |
|
|
2016
Q4 | – | Sell |
-99,344
| Closed | -$7.75M | – | 2730 |
|
|
2016
Q3 | $7.75M | Buy |
99,344
+916
| +0.9% | +$66.5K | 0.03% | 526 |
|
|
2016
Q2 | $6.76M | Buy |
+98,428
| New | +$6.79M | 0.02% | 517 |
|
|
2016
Q1 | – | Sell |
-30,497
| Closed | -$1.9M | – | 1619 |
|
|
2015
Q4 | $1.9M | Buy |
+30,497
| New | +$1.86M | 0.01% | 814 |
|
|
2014
Q2 | – | Sell |
-20,927
| Closed | -$706K | – | 1250 |
|
|
2014
Q1 | $706K | Sell |
20,927
-22,816
| -52% | -$753K | ﹤0.01% | 898 |
|
|
2013
Q4 | $1.48M | Buy |
+43,743
| New | +$1.52M | 0.01% | 740 |
|
Arrowstreet Capital's CMD Position: Q2 2021 in Review
Arrowstreet Capital sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 134,643 shares — an estimated $10.8M sold.
Arrowstreet Capital first reported a position in CMD in Q4 2013 and held it in 9 quarters. The position peaked at $10.8M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Arrowstreet Capital reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Arrowstreet Capital sold 134,643 Cantel Medical Corporation shares in Q2 2021, an estimated $10.8M.
- Arrowstreet Capital first reported a position in Cantel Medical Corporation in Q4 2013 and held it in 9 quarters.
- Arrowstreet Capital's Cantel Medical Corporation position peaked at $10.8M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Arrowstreet Capital's 13F filing for Q2 2021, filed 13 Aug 2021.